CHINA BIOLOGIC PRODS INC's ticker is CBPOXXXX and the CUSIP is 16938C106. A total of 115 filers reported holding CHINA BIOLOGIC PRODS INC in Q4 2015. The put-call ratio across all filers is 1.08 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $238,000 | +13.3% | 2,101 | 0.0% | 0.00% | – |
| Q1 2017 | $210,000 | -7.1% | 2,101 | 0.0% | 0.00% | – |
| Q4 2016 | $226,000 | -13.7% | 2,101 | 0.0% | 0.00% | – |
| Q3 2016 | $262,000 | +17.5% | 2,101 | 0.0% | 0.00% | – |
| Q2 2016 | $223,000 | +14.4% | 2,101 | +23.5% | 0.00% | – |
| Q1 2016 | $195,000 | +52.3% | 1,701 | +88.8% | 0.00% | – |
| Q4 2015 | $128,000 | +103.2% | 901 | +28.5% | 0.00% | – |
| Q3 2015 | $63,000 | – | 701 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SPQ Asia Capital Ltd | 287,277 | $35,760,000 | 28.32% |
| WARBURG PINCUS LLC | 6,674 | $830,780,000 | 13.45% |
| Ariose Capital Management Ltd | 238,841 | $27,689,000 | 7.56% |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 12,600 | $1,568,000 | 4.48% |
| RUDMAN ERROL M | 37,001 | $4,606,000 | 3.72% |
| INDUS CAPITAL PARTNERS, LLC | 245,237 | $30,527,000 | 2.89% |
| Ativo Capital Management LLC | 93,784 | $11,674,000 | 2.70% |
| OBERWEIS ASSET MANAGEMENT INC/ | 63,305 | $7,880,000 | 2.27% |
| Point72 Hong Kong Ltd | 31,500 | $3,921,000 | 2.14% |
| Cormorant Asset Management, LP | 112,867 | $14,050,000 | 1.55% |